Interview with the Italian researcher Andrea Savarino reveals research on 211 people, showing how prophylaxis with hydroxychloroquine prevents the infection of Covid-19.
The result of a COVID-19 prophylaxis experiment in people exposed to coronavirus positive individuals has been published in the journal International Journal of Antimicrobial Agents, the official body of the International Society of Antimicrobial Chemotherapy. On February 15, a health worker tested positive for SARS-CoV-2. The operator had walked freely through all the wards of the hospital, where she served. It was not possible to quarantine all those who had come into contact with the operator, the health activity would have stopped. On February 25, another person was also infected. The next day, February 26, the first post-exposure hydroxychloroquine-based prophylaxis experiment (440 mg / day) began, for as many as 211 people, including healthcare professionals and patients. After 10 days, nobody tested positive for coronavirus. To understand what this research means, we ask Andrea Savarino, a researcher from the Istituto Superiore di Sanità, and one of the leading experts of hydroxychloroquine at an international level for his publications on the matter, but also because he was the one who proposed the use of the hydroxychloroquine in 2003, to counter Sars1.
To read the interview with the Italian researcher Andrea Savarino: https://www.iltempo.it/cronache/2020/04/21/news/coronavirus-idrossiclorochina-ricerca-malaria-andrea-savarino-trump-zelenko-clorochina-anti-malaria
To read the findings published in International Journal of Antimicrobial Agents: https://www.sciencedirect.com/science/article/pii/S092485792030145X?via=ihub